$0.00
(+0.00%
) Quote detailsUSD
+$0.00
(+0.00%
)At Close (As of Oct 14, 2025)
$3.08B
Market Cap
-
P/E Ratio
-3.55
EPS
$46.00
52 Week High
$26.74
52 Week Low
HEALTHCARE
Sector
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Xenon Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company based in Burnaby, Canada, focused on developing innovative therapies for patients with neurological disorders. With a robust pipeline of drug candidates, Xenon employs advanced technologies to target genetic and rare conditions, aiming to transform patient care. The company’s commitment to scientific excellence and patient outcomes positions it as a key player in the biopharmaceutical landscape, catering to both national and international markets.